Profund Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
26,620
-11,374
-30% -$663K 0.06% 239
2025
Q4
$2.05M Buy
37,994
+5,470
+17% +$263K 0.06% 211
2025
Q3
$1.47M Sell
32,524
-677
-2% -$31.6K 0.05% 249
2025
Q2
$1.54M Sell
33,201
-950
-3% -$46.6K 0.06% 226
2025
Q1
$2.08M Sell
34,151
-1,397
-4% -$81.4K 0.09% 170
2024
Q4
$2.01M Sell
35,548
-7,293
-17% -$407K 0.07% 182
2024
Q3
$2.22M Buy
42,841
+1,047
+3% +$49.1K 0.08% 171
2024
Q2
$1.74M Sell
41,794
-648
-2% -$29K 0.06% 196
2024
Q1
$2.3M Sell
42,442
-2,751
-6% -$140K 0.09% 156
2023
Q4
$2.32M Buy
45,193
+3,040
+7% +$160K 0.1% 155
2023
Q3
$2.45M Sell
42,153
-646
-2% -$39.6K 0.14% 135
2023
Q2
$2.74M Buy
42,799
+925
+2% +$62K 0.15% 107
2023
Q1
$2.9M Sell
41,874
-672
-2% -$47.4K 0.18% 93
2022
Q4
$3.06M Sell
42,546
-671
-2% -$50.6K 0.2% 96
2022
Q3
$3.07M Sell
43,217
-2,668
-6% -$194K 0.22% 86
2022
Q2
$3.53M Sell
45,885
-6,130
-12% -$467K 0.22% 81
2022
Q1
$3.8M Sell
52,015
-7,848
-13% -$527K 0.16% 105
2021
Q4
$3.73M Buy
59,863
+1,558
+3% +$91.4K 0.12% 141
2021
Q3
$3.45M Buy
58,305
+410
+0.7% +$27K 0.12% 147
2021
Q2
$3.87M Buy
57,895
+382
+0.7% +$24.9K 0.13% 130
2021
Q1
$3.63M Sell
57,513
-6,054
-10% -$377K 0.14% 126
2020
Q4
$3.94M Buy
63,567
+112
+0.2% +$6.89K 0.17% 103
2020
Q3
$3.83M Sell
63,455
-12,475
-16% -$751K 0.2% 91
2020
Q2
$4.46M Buy
75,930
+14,930
+24% +$893K 0.25% 75
2020
Q1
$3.4M Sell
61,000
-17,024
-22% -$1.04M 0.26% 73
2019
Q4
$5.01M Buy
78,024
+23,476
+43% +$1.34M 0.22% 87
2019
Q3
$2.77M Sell
54,548
-8,622
-14% -$405K 0.14% 129
2019
Q2
$2.87M Sell
63,170
-10,046
-14% -$468K 0.14% 138
2019
Q1
$3.49M Sell
73,216
-3,874
-5% -$193K 0.17% 114
2018
Q4
$4.01M Sell
77,090
-18,094
-19% -$972K 0.25% 75
2018
Q3
$5.91M Buy
95,184
+22,431
+31% +$1.33M 0.22% 73
2018
Q2
$4.03M Sell
72,753
-6,106
-8% -$330K 0.16% 108
2018
Q1
$4.99M Sell
78,859
-4,279
-5% -$275K 0.2% 81
2017
Q4
$5.09M Sell
83,138
-22,232
-21% -$1.39M 0.2% 82
2017
Q3
$6.72M Buy
105,370
+3,018
+3% +$176K 0.28% 54
2017
Q2
$5.7M Buy
102,352
+447
+0.4% +$24.3K 0.26% 63
2017
Q1
$5.54M Buy
101,905
+6,928
+7% +$380K 0.25% 63
2016
Q4
$5.55M Sell
94,977
-10,509
-10% -$575K 0.26% 56
2016
Q3
$5.69M Sell
105,486
-1,321
-1% -$84.9K 0.27% 58
2016
Q2
$7.86M Sell
106,807
-9,897
-8% -$699K 0.38% 29
2016
Q1
$7.46M Sell
116,704
-31,520
-21% -$1.99M 0.39% 30
2015
Q4
$10.2M Sell
148,224
-6,562
-4% -$434K 0.48% 27
2015
Q3
$9.16M Sell
154,786
-44,549
-22% -$2.83M 0.52% 25
2015
Q2
$13.3M Buy
199,335
+2,315
+1% +$153K 0.55% 25
2015
Q1
$12.7M Buy
197,020
+10,746
+6% +$673K 0.49% 25
2014
Q4
$11M Buy
186,274
+20,375
+12% +$1.15M 0.45% 28
2014
Q3
$8.49M Buy
165,899
+23,988
+17% +$1.2M 0.4% 34
2014
Q2
$6.88M Sell
141,911
-4,852
-3% -$239K 0.3% 42
2014
Q1
$7.62M Buy
146,763
+20,804
+17% +$1.11M 0.35% 33
2013
Q4
$6.7M Buy
125,959
+8,189
+7% +$417K 0.3% 37
2013
Q3
$5.45M Buy
117,770
+2,353
+2% +$103K 0.29% 40
2013
Q2
$5.16M Buy
+115,417
New +$5.01M 0.36% 38

Other funds holding BMY

Profund Advisors's BMY Position: Q1 2026 in Review

Profund Advisors reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q1 2026, selling an estimated $663K and leaving 26,620 shares worth $1.61M. The position accounts for 0.06% of the portfolio, ranked #239.

Profund Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.3M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Profund Advisors held 26,620 shares of Bristol-Myers Squibb worth $1.61M as of Q1 2026.
  • Profund Advisors sold 11,374 Bristol-Myers Squibb shares in Q1 2026, an estimated $663K.
  • Bristol-Myers Squibb made up 0.06% of Profund Advisors's portfolio in Q1 2026, its #239 holding.
  • Profund Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Profund Advisors's Bristol-Myers Squibb position peaked at $13.3M in Q2 2015.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.